Blood Thinners for
Pulmonary Embolism Treatment

Janssen—Your Partner for Cost Support

At Janssen, we don’t want cost to get in the way of treatment you need. We can help you explore options to lower your out-of-pocket cost for XARELTO®.

XARELTO® is proven to treat and help reduce the risk of PE blood clots from happening again.

See how XARELTO® (rivaroxaban) compares to other blood thinners

Specific product characteristics are from the individual full Prescribing Information. Direct comparisons of safety and effectiveness cannot be made. There are different treatment options out there to consider for your condition. Please talk with your healthcare provider to determine the appropriate therapy.

  Does not need to be started with an injectable blood thinner DOAC (direct oral anticoagulant) No routine blood monitoring Once-daily dosing* No known food restrictions Begins working quickly Has a reversal agent
XARELTO®
(rivaroxaban)
             
Warfarin
(Coumadin®, Jantoven®)
             
Eliquis®
(apixaban)
             
Pradaxa®
(dabigatran)
             
Savaysa®
(edoxaban)
             
Aspirin              

*The starting dosage for the first 21 days on XARELTO® is 15 mg twice a day with food. On the 22nd day, the recommended dose is 20 mg once a day with food for the remainder of your treatment.

Aspirin is not recommended for the initial treatment of pulmonary embolism (PE). However, it may be taken to reduce the risk of another PE after you complete initial treatment.

Evaluating different blood thinners for pulmonary embolism (PE)

Unlike warfarin, XARELTO® and apixaban can be started immediately after you are diagnosed with a PE. Warfarin and some other oral blood thinners require you to receive injectable blood-thinning medication for a few days before starting them.

When it comes to dosing, XARELTO® is a blood thinner that can be taken once a day after the first 21 days without first being treated with an injectable blood thinner.*

*The starting dosage for the first 21 days on XARELTO® is 15 mg twice a day with food. On the 22nd day, the recommended dose is 20 mg once a day with food for the remainder of your treatment.

DOACs vs warfarin

XARELTO® and other DOACs (direct oral anticoagulants) are different from older medicines like warfarin because they don't require routine blood monitoring and have fewer drug interactions. When it comes to side effects, some DOACs have higher rates of gastrointestinal bleeding when compared to warfarin, but have a similar or lower risk of major bleeding, like bleeding into the brain. They also begin working faster and tend to leave the system more quickly, which is beneficial if you plan to have any surgical procedures. Read more about the differences between XARELTO® and warfarin.

Sticking with your pulmonary embolism (PE) treatment

If you’ve been prescribed XARELTO® to treat your PE, it’s important to take it as prescribed for as long as your healthcare professional tells you to.

The typical duration of treatment for the first PE event is at least six months. Certain risk factors may put you at ongoing risk for another PE, even after you’ve completed initial treatment. Learn more about how XARELTO® can help you manage this risk.

Sign up for ongoing educational support from Janssen CarePath

Learn about savings options and get help to stay on track with useful information and tools when you register for Janssen CarePath Patient Support for XARELTO®.